Clinical Trials Arena on MSN
Padcev-Keytruda notches another phase III win in bladder cancer
Following the positive outcome, Pfizer and Astellas will seek approval of Padcev-Keytruda in MIBC regardless of a patient’s ...
2don MSN
Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda
Pfizer (PFE) and Astellas Pharma (ALPMY) announced on Wednesday that their antibody drug conjugate Padcev, with Merck’s (MRK) ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Merck & Co.’s cancer immunotherapy Keytruda is one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback